Humoral immune responses and safety of experimental formulations of inactivated Neospora vaccines

Parasitology Research

Volumn 86, Issue 10, 2000, Pages 851-853

  Choromanski, Leszek ^a   Block, Wolfgang ^b  

^a BAYER CORPORATION   (United States)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMORAL IMMUNITY; INJECTION SITE; NEOSPORA; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION;

EID: 0033814495     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008512     Document Type: Article

References (11)

1. Evidence of vertical transmission of Neospora sp. infection in dairy cattle
2. Experimental reproduction of bovine fetal Neospora infection and death with a bovine Neospora isolate
3. An overview of the prevalence and pathogenesis of bovine neosporosis
4. Neosporosis. Report of the International Neospora Workshop
5. Neosporosis: Its prevalence and economic impact
6. In vitro isolation and characterization of a Neospora sp. from aborted bovine fetuses
7. Detection of serum antibody responses in cattle with natural or experimental Neospora infections
8. Newly recognized fatal protozoan disease of dogs
9. Neonatal Neospora caninum infection in dogs: Isolation of the causative agent and experimental transmission
10. Detection of Neospora sp. from infected bovine tissues by PCR probe hybridization
11. Dogs are definitive hosts of Neospora caninum